These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 22194963)

  • 1. Understanding and classifying metabolite space and metabolite-likeness.
    Peironcely JE; Reijmers T; Coulier L; Bender A; Hankemeier T
    PLoS One; 2011; 6(12):e28966. PubMed ID: 22194963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug repositioning for enzyme modulator based on human metabolite-likeness.
    Lee YH; Choi H; Park S; Lee B; Yi GS
    BMC Bioinformatics; 2017 May; 18(Suppl 7):226. PubMed ID: 28617219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing the chemical spaces of metabolites and available chemicals: models of metabolite-likeness.
    Gupta S; Aires-de-Sousa J
    Mol Divers; 2007 Feb; 11(1):23-36. PubMed ID: 17447158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 'Metabolite-likeness' as a criterion in the design and selection of pharmaceutical drug libraries.
    Dobson PD; Patel Y; Kell DB
    Drug Discov Today; 2009 Jan; 14(1-2):31-40. PubMed ID: 19049901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural diversity of biologically interesting datasets: a scaffold analysis approach.
    Khanna V; Ranganathan S
    J Cheminform; 2011 Aug; 3():30. PubMed ID: 21824432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physiochemical property space distribution among human metabolites, drugs and toxins.
    Khanna V; Ranganathan S
    BMC Bioinformatics; 2009 Dec; 10 Suppl 15(Suppl 15):S10. PubMed ID: 19958509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BioSM: metabolomics tool for identifying endogenous mammalian biochemical structures in chemical structure space.
    Hamdalla MA; Mandoiu II; Hill DW; Rajasekaran S; Grant DF
    J Chem Inf Model; 2013 Mar; 53(3):601-12. PubMed ID: 23330685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MetExpert: An expert system to enhance gas chromatography‒mass spectrometry-based metabolite identifications.
    Qiu F; Lei Z; Sumner LW
    Anal Chim Acta; 2018 Dec; 1037():316-326. PubMed ID: 30292308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How diverse are diversity assessment methods? A comparative analysis and benchmarking of molecular descriptor space.
    Koutsoukas A; Paricharak S; Galloway WR; Spring DR; Ijzerman AP; Glen RC; Marcus D; Bender A
    J Chem Inf Model; 2014 Jan; 54(1):230-42. PubMed ID: 24289493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can 'Bacterial-Metabolite-Likeness' model improve odds of 'in silico' antibiotic discovery?
    Cherkasov A
    J Chem Inf Model; 2006; 46(3):1214-22. PubMed ID: 16711741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Not Drug-like, but Like Drugs: Cnidaria Natural Products.
    Laguionie-Marchais C; Allcock AL; Baker BJ; Conneely EA; Dietrick SG; Kearns F; McKeever K; Young RM; Sierra CA; Soldatou S; Woodcock HL; Johnson MP
    Mar Drugs; 2021 Dec; 20(1):. PubMed ID: 35049897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 'rule of 0.5' for the metabolite-likeness of approved pharmaceutical drugs.
    O Hagan S; Swainston N; Handl J; Kell DB
    Metabolomics; 2015; 11(2):323-339. PubMed ID: 25750602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-likeness analysis of traditional Chinese medicines: prediction of drug-likeness using machine learning approaches.
    Tian S; Wang J; Li Y; Xu X; Hou T
    Mol Pharm; 2012 Oct; 9(10):2875-86. PubMed ID: 22738405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolite profiling elucidates communalities and differences in the polyphenol biosynthetic pathways of red and white Muscat genotypes.
    Degu A; Morcia C; Tumino G; Hochberg U; Toubiana D; Mattivi F; Schneider A; Bosca P; Cattivelli L; Terzi V; Fait A
    Plant Physiol Biochem; 2015 Jan; 86():24-33. PubMed ID: 25461697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KNApSAcK Metabolite Activity Database for retrieving the relationships between metabolites and biological activities.
    Nakamura Y; Afendi FM; Parvin AK; Ono N; Tanaka K; Hirai Morita A; Sato T; Sugiura T; Altaf-Ul-Amin M; Kanaya S
    Plant Cell Physiol; 2014 Jan; 55(1):e7. PubMed ID: 24285751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolomics of medicinal plants: the importance of multivariate analysis of analytical chemistry data.
    Okada T; Afendi FM; Altaf-Ul-Amin M; Takahashi H; Nakamura K; Kanaya S
    Curr Comput Aided Drug Des; 2010 Sep; 6(3):179-96. PubMed ID: 20550511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cheminformatics approach to exploring and modeling trait-associated metabolite profiles.
    Ash JR; Kuenemann MA; Rotroff D; Motsinger-Reif A; Fourches D
    J Cheminform; 2019 Jun; 11(1):43. PubMed ID: 31236709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Untargeted metabolomics and DNA barcoding for discrimination of Phyllanthus species.
    Kiran KR; Swathy PS; Paul B; Shama Prasada K; Radhakrishna Rao M; Joshi MB; Rai PS; Satyamoorthy K; Muthusamy A
    J Ethnopharmacol; 2021 Jun; 273():113928. PubMed ID: 33631274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of Drug-like Chemical Space for Cytotoxic Marine Metabolites Using Multivariate Methods.
    Jagannathan R
    ACS Omega; 2019 Mar; 4(3):5402-5411. PubMed ID: 31179404
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.